Hotchkis & Wiley Capital Management LLC Bristol Myers Squibb CO Transaction History

Hotchkis & Wiley Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $147 Million - $161 Million	-2,018,300 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $26.9 Million - $32.2 Million	-437,140 Reduced 17.8%	2,018,300 $147 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $1.71 Million - $1.99 Million	-31,803 Reduced 1.28%	2,455,440 $153 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $4.91 Million - $5.75 Million	-82,900 Reduced 3.23%	2,487,243 $147 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $9.13 Million - $9.94 Million	-147,497 Reduced 5.43%	2,570,143 $172 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $1.36 Million - $1.53 Million	-22,900 Reduced 0.84%	2,717,640 $172 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $158 Million - $179 Million	2,740,540 New	2,740,540 $170 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hotchkis & Wiley Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hotchkis & Wiley Capital Management LLC with notifications on news.